Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A

Brain and Development

Volumn 32, Issue 8, 2010, Pages 685-687

  Miyata, Rie ^a   Sasaki, Toru ^b   Hayashi, Masaharu ^c   Araki, Satoshi ^d   Shimohira, Masayuki ^d   Kohyama, Jun ^a  

^a Tokyo Kita Shakai Hoken Hospital   (Japan)

^b Tokyo Kita Shakai Hoken Hospital   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Basal ganglia; Dopamine; Laryngeal dystonia; Levodopa; Xeroderma pigmentosum

Indexed keywords

LEVODOPA;

ADULT; AGED; AIRWAY OBSTRUCTION; ARM; ARTICLE; BRAIN ATROPHY; BRAIN STEM; CASE REPORT; CEREBELLUM; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GENE MUTATION; HEARING AID; HUMAN; LIMB; LOW DRUG DOSE; MALE; MOVEMENT (PHYSIOLOGY); MUSCLE TONE; MUSCLE WEAKNESS; NEUROGENIC BLADDER; NUCLEAR MAGNETIC RESONANCE IMAGING; SPASMODIC DYSPHONIA; STRIDOR; VOCAL CORD; VOCAL CORD PARALYSIS; WAKEFULNESS; XERODERMA PIGMENTOSUM;

EID: 77955412440     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2009.09.008     Document Type: Article

References (10)

1. Kraemer K.H., Patronas N.J., Schiffmann R., Brooks B.P., Tamura D., Digiovanna J.J. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 2007, 145:1388-1396.
2. Nishigori C., Moriwaki S., Takebe H., Tanaka T., Imamura S. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Arch Dermatol 1994, 130:191-197.
3. Hamano K., Kumada S., Hayashi M., Naito R., Hayashida T., Uchiyama A., et al. Laryngeal dystonia in a case of severe motor and intellectual disabilities due to Japanese encephalitis sequelae. Brain Dev 2004, 26:335-338.
4. Muto H., Matsui A., Saito Y., Iwamoto H., Kaneko K., Masuko K., et al. Laryngeal dystonia in xeroderma pigmentosum. Brain Dev 2005, 27:598-601.
5. Ohto T., Iwasaki N., Okubo H., Shin K., Matsui A. Life-threatening vocal cord paralysis in a patient with group A xeroderma pigmentosum. Pediatr Neurol 2004, 30:222-224.
6. Hayashi M., Araki S., Kohyama J., Shioda K., Fukatsu R., Tamagawa K. Brainstem and basal ganglia lesions in xeroderma pigmentosum group A. J Neuropathol Exp Neurol 2004, 63:1048-1057.
7. Grillone G.A., Chan T. Laryngeal dystonia. Otolaryngol Clin North Am 2006, 39:87-100.
8. Nomura Y., Segawa M. Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis. Brain Dev 2003, 25:S37-S42.
9. Margolese H.C., Chouinard G., Kolivakis T.T., Beauclair L., Miller R. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: Pathophysiology and mechanisms of induction. Can J Psychiatry 2005, 50:541-547.
10. Rowley H., Lynch T., Keogh I., Russell J. Tardive dystonia of the larynx in a quadriplegic patient: an unusual cause of stridor. J Laryngol Otol 2001, 115:918-919.